SCHEMBL31056902

SCHEMBL31056902

COC(=O)c1ccc(C2CNCCN2)cc1F

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CTSL P07711 1/20 0.40
CTSB P07858 1/20 0.40
CTSS P25774 1/20 0.40
CTSK P43235 1/20 0.40
SLC6A2 P23975 5/20 0.39
SLC6A4 P31645 5/20 0.39
HTR2A P28223 1/20 0.36
KCNH2 Q12809 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
SGK1 O00141 2/20 0.36
RPS6KB1 P23443 2/20 0.36
AKT1 P31749 2/20 0.36
AKT2 P31751 2/20 0.36
PRKCQ Q04759 2/20 0.36
ROCK1 Q13464 2/20 0.36
RPS6KA1 Q15418 2/20 0.36
AKT3 Q9Y243 2/20 0.36
ROCK2 O75116 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29325561 1.00 CTSL (0.40) CTSLCTSBCTSSCTSKSLC6A2
SCHEMBL31056427 0.86 CTSL (0.38) CTSLCTSBCTSSCTSKSLC6A2
SCHEMBL29325641 0.86 CTSL (0.38) CTSLCTSBCTSSCTSKSLC6A2
SCHEMBL29320338 0.86 CA12 (0.48) CTSLCTSBCTSSCTSKSLC6A2
SCHEMBL29321284 0.85 ALDH1A1 (0.48) CTSLCTSBCTSSCTSKSLC6A2
SCHEMBL29320158 0.84 CTSL (0.39) CTSLCTSBCTSSCTSKSLC6A2
SCHEMBL17782196 0.82 PARP1 (0.46)
SCHEMBL17782195 0.82 PARP1 (0.46)
SCHEMBL31385923 0.80 HTR2A (0.49) HTR2A
SCHEMBL25076663 0.79 ALDH1A1 (0.36) SLC6A2SLC6A4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4739675-A1 INDOLE DERIVATIVES WITH FACTOR B INHIBITORY ACTIVITY Sitala Bio Ltd (GB) 2026-05-13 EP disclosed
WO-2025008517-A1 INDOLE DERIVATIVES WITH FACTOR B INHIBITORY ACTIVITY SITALA BIO LTD (GB) 2025-01-09 WO disclosed
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 WO disclosed